It’s why we’re innovating with virtual
trials that let patients participate from
their homes, and tapping into wearable devices to make data-collection easier
and more reliable.
It’s why we’re using AI and machine learning to deliver
centralized monitoring and automated safety case processing to make trials safer and
It’s also why we are incorporating unparalleled, clinically-rich, real world data into your trial designs to drive efficiencies and reduce uncertainties and delays.
HOW THE IQVIA CORE CAN POWER CHANGE IN CLINICAL DEVELOPMENT.
Can the $150-160B that pharmaceutical and other medical science
companies spend collectively on research and development be focused more precisely and used more effectively?
READ THE ARTICLE